Perceptive Advisors’s Tango Therapeutics TNGX Stock Holding History

Perceptive Advisors’s Portfolio TNGX Stock Details TNGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$106M	Buy	3,377,000 +2,568,847	+318%	+$63.5M	1.58%	20
2026 Q1	$16.9M	Buy	808,153 +295,118	+58%	+$4.11M	0.33%	57
2025 Q4	$4.55M	Buy	+513,035	New	+$4.42M	0.08%	96
2024 Q1	–	Sell	-1,111,870	Closed	-$11M	–	124
2023 Q4	$11M	Sell	1,111,870 -1,307,098	-54%	-$11.3M	0.25%	64
2023 Q3	$27.2M	Buy	+2,418,968	New	+$14.8M	0.91%	34
2021 Q3	–	Sell	-500,000	Closed	-$5.69M	–	158
2021 Q2	$5.69M	Hold	500,000	–	–	0.07%	122
2021 Q1	$5.56M	Hold	500,000	–	–	0.07%	112
2020 Q4	$5.72M	Hold	500,000	–	–	0.06%	118
2020 Q3	$5.18M	Buy	+500,000	New	+$5.11M	0.08%	101

Other funds holding TNGX

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

BCM

Boxer Capital Management San Diego, California $1.33B AUM 864.5% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

TCM

TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return

PBA

Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

Perceptive Advisors's TNGX Position: Q2 2026 in Review

Perceptive Advisors increased its Tango Therapeutics (TNGX) stake by 318% in Q2 2026, buying an estimated $63.5M and bringing the position to 3,377,000 shares worth $106M. The position accounts for 1.58% of the portfolio, ranked #20.

Perceptive Advisors first reported a position in TNGX in Q3 2020 and has held it in 9 quarters since. 248 funds tracked by Wall St. Rank hold TNGX as of Q2 2026.

Perceptive Advisors held 3,377,000 shares of Tango Therapeutics worth $106M as of Q2 2026.
Perceptive Advisors bought 2,568,847 Tango Therapeutics shares in Q2 2026, an estimated $63.5M.
Tango Therapeutics made up 1.58% of Perceptive Advisors's portfolio in Q2 2026, its #20 holding.
Perceptive Advisors first reported a position in Tango Therapeutics in Q3 2020 and has held it in 9 quarters since.
248 funds tracked by Wall St. Rank held Tango Therapeutics as of Q2 2026.

Based on Perceptive Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.